Sponsored by:

AHA Scientific Sessions 2009

Orlando, Florida; November 14-18

AHA 2009
Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Wednesday November 18 2009

  • A Cluster Randomized Trial of Public Report Cards for Improving the Quality of Cardiac Care: Results from the Canadian Cardiovascular Outcomes Research Team's (CCORT) Enhanced Feedback for Effective Cardiac Treatment (EFFECT) Study – Jack V. Tu

  • Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT) – Gilbert L. Raff

  • Long-term Follow-up in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) – William Cushman

  • Randomised Dabigatran Etexilate Dose Finding Study in Patients with Acute Coronary Syndromes Post Index Event with Additional Risk Factors for Cardiovascular Complications Also Receiving Aspirin and Clopidogrel (RE-DEEM) – Jonas Oldgren

Tuesday November 17 2009

  • Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI2D) Trial – Bernard R. Chaitman, Maria M. Brooks, Mark Hlatky

  • Comparison of Low-Dose Versus High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin Converting Enzyme Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (HEAAL) – Marvin A. Konstam

  • Iron Assessment in Patients with Iron Deficiency and Chronic Heart Failure With and Without Anemia (FAIR-HF) – Stefan D. Anker

  • Randomized Trial to Optimize the Dose and Efficacy of Beta-Blocker in Systolic Heart Failure: Japanese Chronic Heart Failure Study (J-CHF) – Mosatsugu Hori

  • Outcomes of Patients with Advanced Heart Failure Treated with Either a Pulsatile or Continuous Flow Left Ventricular Assist Device: Results of the HeartMate II Destination Therapy Trial – Joseph G. Rogers

Monday November 16 2009

  • Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison Between Hospitals With and Without Cardiac Surgery On-Site – Ather Anis

  • ARBITER 6-HALTS: The Effect of Extended-release Niacin or Ezetimibe Added to Chronic Statin Therapy on Carotid Intima Media Thickness – Allen J. Taylor

  • Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) – Mark A. Pfeffer

  • Clopidogrel and Aspirin Versus Aspirin Alone After Coronary Bypass Surgery: Results from the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) Randomized Controlled Trial – Alexander Kulik

  • Long-term Neurocognitive Outcome After Off-pump Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention (OCTOPUS) – Jakub Regieli

  • Telephone-Delivered Collaborative Care for Treating Post-CABG Depression: 8-Month Outcomes from The Bypassing The Blues Trial – Bruce L. Rollman

  • Non-Steroidal Anti-Inflammatory Treatment for Post-operative Pericardial Effusion: The POPE Study – Philippe Meurin

Sunday November 15 2009

  • Do Point-of-Care Platelet Function Assays Predict Clinical Outcomes in Clopidogrel Pretreated Patients Undergoing Elective PCI (POPULAR Study) – Nicoline J. Breet

  • The Results of the CHAMPION PCI Trial – Robert A. Harrington

  • The Results of the CHAMPION PLATFORM Trial – Deepak L. Bhatt

  • Comparison of Ticagrelor, the First Reversible Oral P2Y12 Receptor Antagonist, with Clopidogrel in Patients with ST-Elevation Acute Coronary Syndromes (PLATO) – P. Gabriel Steg

  • Efficacy and Safety of Dabigatran Compared to Warfarin at Different Levels of INR Control for Stroke Prevention in 18,113 Patients with Atrial Fibrillation in the RE-LY Trial – Lars C. Wallentin

  • Results of the Pacing to Avoid Cardiac Enlargement (PACE) Trial – Cheuk-man Yu

  • Differences in Clinical Outcomes with Rhythm-and Rate-control Therapies for Atrial Fibrillation in the Record-AF Registry – John Camm